Materials and instruments
General chemicals available from commercial sources and used as received without further purified. The twicedistilled water used for the biological studies was used throughout all experiments. Buffer reagents were purchased from Aldrich and Acros. Melting points were measured on an electrothermal melting point apparatus. HRMS spectra were performed by the mass spectrometry facilities in the Shandong Analysis and Test Center. 1 H-NMR and 13 C-NMR were recorded on a Bruker 400 MHz NMR spectrometer. Fluorescence spectra and absorption spectra were got from a Thermo Varioskan microplate reader. Fluorescence imaging of cells was performed on a Zeiss Axio Observer A1 fluorescence microscope. Quantum yields of these probes were measured by HitachiF-2500 fluorescent spectrometer, Shimadzu UV-2401PC UV−visible spectrometer and WAY-2S Abbe refractometer. Analytical HPLC was performed on Agilent Technologies 1260 Series using a C8 reversed phase column (250 x 4.60mm , Phenomenex).
Docking study for probe 10 with MDM2
The initial three-dimensional geometric coordinates of the X-ray crystal structure of MDM2 (PDB code: 1T4E) was downloaded from the Protein Data Bank (http://www.pdb.org/pdb/home/home.do). Then we used GOLD 5.1with Gold Score fitness function to dock 3b into its targets for testing the binding conformation of the complex as we reported previously 1 .
Synthesis

Characterization of 7-chlorobenzo[c] [1, 2, 5] oxadiazole-4-sulfonyl chloride (intermediate 3)
Chlorine acid (5 mL) was added in a 250 mL round bottom flask, 4-chlorobenzo[c] [1, 2, 5] oxadiazole (0.52 g, 3.36 mmol) was added in in portion wise and the mixture was heated at 120-130 °C for 6h. Then, the solution was cooled to room temperature. After cooling, the mixture was poured into ice slowly, and the precipitate was filtered and washed with water. The yellow product was obtained by recrystallizing from petroleum ether and benzene.
A yellow solid, Yield: 0.42 g, 71.0%. M.p.:87-88°C. 1 H-NMR (400 MHz, CDCl 3 ): δ 8. 21-8.17(m, 1H), 7.68-7.66(m, 1H) . A solution of ethylenediamine (1 mL) and compound 4 (50.0 mg, 0.19 mmol) in 4 mL acetonitrile was stirred for 6 h at 60 °C. Then, the solvent was removed under reduced pressure, and the yellow product 5 was obtained by column chromatography on silica gel (dichloromethane: methanol = 10:1).
A yellow solid, Yield: 0.05 g. 92.3%. M.p.:132-135°C. 1 H-NMR (CDCl 3 , 400 MHz): δ 7.90(d, J = 6.0 Hz, 1H), 6.25(s, 1H), 6.15(d, J = 6.0 Hz, 1H), 3.45-3.39(m, 2H), 3.14-3.10(m, 2H), 2.87(s, 6H), 1.31(s, 2H).
Characterization of 7-((3-aminopropyl) amino)-N, N-dimethylbenzo[c] [1, 2, 5] oxadiazole-4-sulfonamide (intermediate 6)
A yellow solid, Yield: 0.11 g. 64.7%. M.p.:108-110°C. 1 HNMR (CDCl 3 , 400 MHz): δ 7.83(d, J = 9.0 Hz, 1H), 6.32(d, J = 9.0 Hz, 1H), 4.12(s, 2H), 3.45(t, J = 6.0 Hz, 2H), 2.69-2.65(m, 8H), 1.79-1.68(m, 2H).
Characterization of 7-((aminomethyl) amino)-N, N-dimethylbenzo[c] [1, 2, 5] oxadiazole-4-sulfonamide (intermediate 7)
A yellow solid, Yield: 0.12 g. 75.0%. M.p.:115-118°C. 1 HNMR (CDCl 3 , 400 MHz): δ 7.83(d, J = 6.0 Hz, 1H), 6.31(d, J = 9.0 Hz, 1H), 4.44(s, 2H), 3.38(t, J = 6.0 Hz, 2H), 2.69(s, 6H), 2.61-2.56(m, 2H), 1.77-1.40(m, 3H). ((1-(3-(1H-imidazol-1-yl) Compound 8 (40.0 mg, 0.09 mmol) and intermediate 5 (77.0 mg, 0.3 mmol) were added to a tube. Then, 1.5 mL acetic acid was added and the mixture reacted under microwave. Two hours later, the solvent was removed and the product 9 was got by column chromatography on silica gel (petroleum: dichloromethane = 33:1). 58, 165.50, 146.44, 144.58, 140.88, 139.94, 139.90,137.27, 134.81, 131.73, 130.67, 129.46, 129.10, 128.14, 126.62 , 122.37, 118.58, 112.28, 109.20, 98.98, 62.55, 44.79, 40.67, 38.53, 37.82, 29.69 89, 165.15, 148.91, 146.42, 144.56, 140.95, 140.35,139.62, 137.25, 135.08, 131.75, 130.42, 129.46, 129.00, 128.23, 126.36, 122.31, 118.44, 112.12, 108.93, 98.63, 62.64, 44.88, 40.52,40.06, 38.68, 37.84, 29.77,29.09 1-(3-(1H-imidazol-1-yl) 80, 165.11, 146.41, 144.50, 140.83, 140.46,139.66, 137.09, 135.28, 131.74, 130.36, 129.51, 129.00, 128.21, 126.38, 122.26, 118.50, 111.73, 109.04, 98.73, 62.67, 44.77, 42.64, 41.58, 38.67, 37.83, 29.70,29.15,25.28 
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Fluorescence spectroscopy test of probes 9-11.
Probe was dissolved in DMSO to acquire 10mM stock solution, respectively. The stock solution of them was diluted in PBS (PH =7.4) to obtain 5 µM solutions. The fluorescent properties of them were obtained on Thermo-Fisher Varioskan microplate reader. The quantum yields of them were calculated under PBS solution (pH = 7.4) and DCM solution, respectively, using fluorescein 0.1 M NaOH (Φ ST = 0.92) as a reference. 
The effect of probes 9-11 to the FP assay
The direct fluorescence response of probe 9-11 to MDM2-p53 was determined on a Multiskan Spectrum Microplate Spectrophotometer. Various concentrations of MDM2 protein at the range of 0.0-0.25 μM were preincubated with p53 peptide (10 nM; ChinaPeptides Co., Ltd.,Shanghai, China) for 30 min. Then, probe 9-11 was added to the mixture, and the final concentration of the probe is 10 μM. After 5-10 min, the emission spectrums at different protein concentration were obtained, which is excited at 440 nm, and we then analyzed the fluorescent intensity at the maximum emission wavelength 543 nm with the changes of MDM2-p53 protein concentration. Table S1 FP value changes of probes 9-11 (100 nM) with increased MDM2 protein concentration using the similar method of FP assay. 
MDM2 binding affinity assay
Briefly, the fluorescence polarization experiments were read on BioTek (Winooski, VT, USA) Synergy H4 with the 485-nm excitation and 535-nm emission filters. The fluorescence intensities parallel (Intparallel) and perpendicular (Intperpedicular) to the plane of excitation were measured in black 96-well NBS assay plates (Corning # 3993) at room temperature. The background fluorescence intensities of blank samples containing the reference buffer were subtracted, and steady-state fluorescence polarization was calculated using the following equation: P = 1000 9 (Intparallel-GIntperpedicular)/(Intparallel + GIntperpedicular), and the correction factor G (G = 0.998 determined empirically) was introduced to eliminate differences in the transmission of vertically and horizontally polarized light. All fluorescence polarization values were expressed in millipolarization units (mP). The dose-dependent binding experiments were carried out with serial dilution in DMSO of compounds. A 5 μL sample of the test sample preincubated (for 30 min) with MDM2 binding domain (1-118) (10 nM) and PMDM-F peptide (Anaspec) (10 nM) in assay buffer (100 mM potassium phosphate, pH 7.5; 100 mg/mL bovine gamma globulin; 0.02% sodium azide) were added to microplates to produce a final volume of 115μL. Plates were read at 1 h after mixing all assay components. Binding constant (K i ) and inhibition curves were fitted using GraphPad Prismsoftware. Nutlin-3a (Sigma-Aldrich, St. Louis,MO, USA) was used as a reference compound for validating the assay in each plate. Using similar protocol, we choose bovine serum albumin (BSA) which often forms non-specific binding with small molecule and MDM2 protein as the control groups to evaluate the selectivity of probe 9-11 to MDM2-p53. The concentration of BSA and MDM2 is identical to MDM2-p53 and then we analyzed the fluorescent intensity at emission wavelength 543 nm with the changes of protein concentration, which is excited at 440 nm.
Fig.S4
The fluorescent properties of probes 9-11 at the emission wavelength 543 nm with a series of concentrations of BSA and MDM2 (0.86 -0 μM), excitated at 440 nm.
In vitro antiproliferative assay of probes 9-11
The cellular growth inhibitory activity of probes was determined by SRB (Sulforhodamine B) assays, using A549 (wild-type p53), H1299 (p53 null), HCT116 (wild-type p53), and MDA-MB-231 (wild-type p53) cells. An amount of (4-6)×10 3 cells per well were placed in 96-well plates with 100 μL culture medium and then cultured in 5% CO2 atmosphere at 37℃ for 12 h. Subsequently, the test compounds were added to the wells at different concentrations for 48 h. Then, 100 μL cold 10% (wt/vol) TCA (Trichloroacetic acid) was added to each well gently and incubated at 4℃. After 1 h, the plates were washed by water purified with a Mill-Q filtration system four times and excess water was removed using paper towels. Then, the plates were dried at room temperature. Once dry, 100μL of 4 g/L SRB solution was added to each well. After shaking for 30 min, the plates were rinsed by 1 %( vol/vol) acetic acid four times to remove unbound dye and dried at room temperature. Then, 100μL of 10 mM Tris base solution (PH 10.5) were added to each well. After shaking for 10 min, the absorbance value of each well was recorded using a microplate reader at 515 nm. Wells containing no compounds were chosen as blanks. The concentration of each probe that inhibited cell growth by 50% (IC 50 ) was calculated. 
